MEGAN BOWLIN: Open Payments
NPI 1407379456 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $36 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, PREVNAR 20, VOQUEZNA, XIFAXAN, BREZTRI, VIVITROL, MOUNJARO.
Industry payments across DE — which companies pay providers there.
